# Leading Venture Capital

> Leading Venture Capital is a VC fund backing Biotechnology, Manufacturing and Pharmaceutical. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: May 2023
- Lead investor: 20%
- Last updated: Aug 2026

Leading Venture Capital is an Investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Manufacturing | 2 | 40% |
| Pharmaceutical | 2 | 40% |
| Medical | 1 | 20% |
| Software | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 40% |
| Series A | 2 | 40% |
| Series C | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 4 | 80% |
| United States | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NeuExcell Therapeutics | NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. We have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.Our vision is to improve the quality of life of millions of patients worldwide who are suffering from neurodegenerative conditions by using the powerof gene therapy to restore damaged neural tissue. | $15M | Seed | May 04, 2023 |  |
| Neowise | XinjingZhiyuan is an immune cell therapy company focusing on solid tumors. | $29M | Series A | Mar 15, 2023 |  |
| Chilye | Chilye is a supplier of high-voltage electrical and distribution management for electric vehicles. | $15.7M | Series C | Feb 10, 2022 |  |
| Qiaochu | Qiaochu Archives is a digital intelligence archives management solution provider. The company focuses on digital intelligence archives management. It conducts scientific, intelligent, and data-based management of the entire life cycle of archives from sorting to permanent preservation or destruction to create a higher Level of comprehensivemanagement services for archive information security. | $15.7M | Series A | Nov 15, 2021 |  |
| Pro-Heal Pharmaceuticals | Pro-Heal Pharmaceuticals is a biotechnology based pharmaceutical manufacturing company. |  | Seed | Mar 01, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 4 deals together
- Suzhou Industrial Park Leader Venture Capital — VC Fund, 2 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- Fujian Haixi Pharmaceuticals — VC Fund, 1 deal together
- [GEM](https://shizune.co/investors/profile/gem-66ef) — VC Fund, 1 deal together
- [Guangzhou Financial Holding Fund Management](https://shizune.co/investors/profile/guangzhou-jinkong-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Leading Venture Capital invest in?

Leading Venture Capital invests primarily in Biotechnology, Manufacturing and Pharmaceutical startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Leading Venture Capital last invest?

The most recent investment recorded for Leading Venture Capital closed in May 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co